The efficacy of antithrombin administration in the acute phase of burn injury

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH07-11-0684
Issue:2008: 100/2 (Aug) pp. 173-364
Pages:286-290

The efficacy of antithrombin administration in the acute phase of burn injury

Athina Lavrentieva1, Theodore Kontakiotis2, Militsa Bitzani1, Aggeliki Parlapani3, Olympia Thomareis3, Harisios Scourtis3, Nicolaos Tsotsolis3, Lambis Lazaridis4, Maria-Amalia Giala3
1Burn Intensive Care Unit, Papanicolaou General Hospital, Thessaloniki, Greece; 2Pulmonary Department, Aristotle University, Thessaloniki, Greece; 3Anesthesiology Department, Aristotle University, Thessaloniki, Greece; 4Plastic Surgery Department, Aristotle University, Thessaloniki, Greece

Summary

Severe burn injury is characterized by the activation of coagulation, decreased fibrinolytic activity and decreased natural anticoagulant activity. The aim of our study was to investigate the effect of antithrombin (AT) administration on coagulation status and on organ function in the early post-burn period.Thirty-one patients were admitted to the burn intensive care unit and were then randomised into two groups (AT-treated and non-ATtreated) for four consecutive days after thermal injury.The clinical data, coagulation and fibrinolysis parameters were compared and the adverse effects were monitored. Significant differences in the time course of coagulation markers (thrombin/AT complexes, tissue plasminogen activator, D-dimer) were observed between AT-treated and non-AT treated groups. According to the International Society onThrombosis and Haemostasis criteria, disseminated intravascular coagulation (DIC) diagnosis was made in 28 of 31 patients.The presence of overt DIC was associated with mortality (p<0.001).The Sequential Organ Failure Assessment (SOFA) score time trend differed significantly between the two investigation groups (decreased in the treated group and did not change in the non-AT-treated group). ATtreated patients had an absolute reduction in a 28-day mortality of 25% as compared to the non-AT-treated group (p=0.004). No treatment related side effects were observed.Treatment withAT seems to affect the coagulation status and reduce multiple organ failure incidence and mortality in the early post-burn period.

Keywords

Antithrombin, disseminated intravascular coagulation, coagulation markers, burn injury, sequential organ failure assessment score

DOI

http://dx.doi.org/10.1160/TH07-11-0684

You may also be interested in...

1.

Moritoki Egi1; Hiroshi Morimatsu1; Christian J. Wiedermann2; Makiko Tani1; Tomoyuki Kanazawa1; Satoshi Suzuki1; Takashi Matsusaki1; Kazuyoshi Shimizu1; Yuichiro Toda1; Tatsuo Iwasaki1; Kiyoshi Morita1

Thrombosis and Haemostasis 2009 101 4: 696-705

http://dx.doi.org/10.1160/TH08-07-0448

2.

Peter Raivio1,Anne Kuitunen2, Jari Petäjä5, Sorella Ilveskero4, Riitta Lassila3,4

Thrombosis and Haemostasis 2008 99 2: 427-434

http://dx.doi.org/10.1160/TH07-04-0307

3.

Saulius Butenas1, Anetta Undas2, Matthew T. Gissel1, Konstanty Szuldrzynski3, Krzysztof Zmudka2, Kenneth G. Mann1

Thrombosis and Haemostasis 2008 99 1: 142-149

http://dx.doi.org/10.1160/TH07-08-0499



Articles

You've 349 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...